Various Proteins, DNA, and Glutathione

Various Proteins, DNA, and Glutathione represents a collective group of cellular nucleophiles that serve as the primary targets for reactive electrophilic drugs and metabolites. DNA is a major therapeutic target for alkylating antineoplastic agents, which form covalent adducts and cross-links that disrupt replication and transcription (Source: NIH National Cancer Institute). These modifications ultimately lead to cell cycle arrest and apoptosis in rapidly dividing malignant cells. Proteins are frequently targeted by reactive intermediates, such as the acetaminophen metabolite NAPQI, resulting in covalent protein adducts (Source: StatPearls). Such protein modifications can cause loss of function, enzyme inactivation, and trigger immune-mediated or direct cellular toxicity, particularly in the liver. Glutathione (GSH) acts as a vital endogenous antioxidant and sacrificial nucleophile that neutralizes these reactive species to prevent damage to DNA and proteins (Source: PubChem). The depletion of glutathione is a hallmark of oxidative stress and a critical step in the pathogenesis of drug-induced organ injury. This collective grouping is significant in pharmacology and toxicology for understanding the non-specific, multi-target mechanisms of covalent modifiers. Because this entry aggregates disparate molecular classes, it is typically used to describe the broad-spectrum reactivity of electrophiles rather than a specific receptor-ligand interaction.

Other names

Cellular nucleophilesBiological macromolecules and thiolsElectrophile targetsCovalent binding targets

Covalent modification of nucleophilic sites via alkylation or arylation, leading to DNA cross-linking, protein adduct formation, and depletion of cellular antioxidant capacity.